Researchers develop new strategy to limit side effects of stem cell transplants
(Rockefeller University Press) Scientists in Germany have developed a new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants. The researchers describe the successful application of their strategy in mice in 'Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion,' which will be published online Aug. 15 ahead of issue in the Journal of Experimental Medicine.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Acute Leukemia | Bone Marrow Transplant | Cancer | Cancer & Oncology | Leukemia | Lymphoma | Stem Cell Therapy | Stem Cells | Transplants